These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32429662)

  • 21. Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors.
    Jiang M; Huizenga MCW; Mohr F; Amedi A; Bakker R; van den Berg RJBHN; Deng H; van der Wel T; van Boeckel CAA; van der Stelt M
    J Med Chem; 2024 Jul; 67(14):12331-12348. PubMed ID: 38988250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ω-Quinazolinonylalkyl aryl ureas as reversible inhibitors of monoacylglycerol lipase.
    Dato FM; Neudörfl JM; Gütschow M; Goldfuss B; Pietsch M
    Bioorg Chem; 2020 Jan; 94():103352. PubMed ID: 31668797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.
    Lauria S; Perrotta C; Casati S; Di Renzo I; Ottria R; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Bioorg Med Chem; 2018 May; 26(9):2561-2572. PubMed ID: 29678535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases.
    Zanfirescu A; Ungurianu A; Mihai DP; Radulescu D; Nitulescu GM
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
    Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
    Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Evaluation of
    Chen Z; Mori W; Fu H; Schafroth MA; Hatori A; Shao T; Zhang G; Van RS; Zhang Y; Hu K; Fujinaga M; Wang L; Belov V; Ogasawara D; Giffenig P; Deng X; Rong J; Yu Q; Zhang X; Papisov MI; Shao Y; Collier TL; Ma JA; Cravatt BF; Josephson L; Zhang MR; Liang SH
    J Med Chem; 2019 Oct; 62(19):8866-8872. PubMed ID: 31518130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the Inhibitory Mechanism of Aryl Formyl Piperidine Derivatives on Monoacylglycerol Lipase through Molecular Dynamics Simulations.
    Liu C; Guan S; E J; Yang Z; Zhang X; Ju J; Wang S; Zhang H
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and preclinical evaluation of [
    Ahamed M; Attili B; van Veghel D; Ooms M; Berben P; Celen S; Koole M; Declercq L; Savinainen JR; Laitinen JT; Verbruggen A; Bormans G
    Eur J Med Chem; 2017 Aug; 136():104-113. PubMed ID: 28486208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational Development of MAGL Inhibitors.
    Granchi C; Rizzolio F; Caligiuri I; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
    Methods Mol Biol; 2018; 1824():335-346. PubMed ID: 30039417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
    Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.
    Hernández-Torres G; Cipriano M; Hedén E; Björklund E; Canales Á; Zian D; Feliú A; Mecha M; Guaza C; Fowler CJ; Ortega-Gutiérrez S; López-Rodríguez ML
    Angew Chem Int Ed Engl; 2014 Dec; 53(50):13765-70. PubMed ID: 25298214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors.
    Aida J; Fushimi M; Kusumoto T; Sugiyama H; Arimura N; Ikeda S; Sasaki M; Sogabe S; Aoyama K; Koike T
    J Med Chem; 2018 Oct; 61(20):9205-9217. PubMed ID: 30251836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).
    Granchi C; Caligiuri I; Minutolo F; Rizzolio F; Tuccinardi T
    Expert Opin Ther Pat; 2017 Dec; 27(12):1341-1351. PubMed ID: 29053063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.